Results 231 to 240 of about 3,750,719 (375)

HLA-B*1502 is associated with aromatic anticonvulsant drug-induced cutaneous adverse drug reactions among the Hakka population in China

, 2020
Zhiyuan Zheng, Hua Zhong, Qunji Zhang, Qingyan Huang, Heming Wu   +4 more
openalex   +1 more source

Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system

Andrology, EarlyView.
Abstract Background Growing evidence indicates that paternal condition significantly influences pregnancy outcomes and offspring health. However, assessing the safety of paternal drug exposure via randomized controlled trials poses ethical challenges, and relevant clinical studies consume a lot of resources to evaluate only a few drugs.
Yanbin Zeng, Wanlong Lin, Wei Zhuang
wiley   +1 more source

Using Immunoliposomes as Carriers to Enhance the Therapeutic Effectiveness of Macamide N-3-Methoxybenzyl-Linoleamide. [PDF]

Neurol Int
Vera-López KJ, Aranzamendi-Zenteno M, Davila-Del-Carpio G, Nieto-Montesinos R.   +3 more
europepmc   +1 more source

Role of anticonvulsant therapeutic drug monitoring in improving clinical outcomes: An example of 12 adult epilepsy patients

, 2012
Rankovic Ana, Jasmina Milovanović, Jankovic Snezana, Todorovic Natalija, Nemanja Rančić, Jestrovic Nikola, Iztok Grabnar, Slobodan Јаnkovic, Jakovljevic Mihajlo   +8 more
openalex   +1 more source

Interrelationships between serum 25-hydroxycalciferol and bone mass in adults on long term antiepileptic drug therapy [PDF]

, 1983
Berlit, Peter, Janz, D., Krause, Klaus-Henning, Meinardi, H., Oxley, J., Schmidt-Gayk, Heinrich   +5 more
core  

Episodic disorders: channelopathies and beyond. [PDF]

, 2015
Ptáček, Louis J
core   +1 more source

Real‐World Therapeutic Hypothermia for Neonatal HIE: Neurodevelopmental Outcomes and Predictors

Acta Paediatrica, EarlyView.
ABSTRACT Aim This study assessed neurodevelopmental outcomes in neonates with hypoxic‐ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) outside randomised controlled trials (RCTs). It also aimed to identify predictors of outcomes and evaluate TH practices across centres.
Luca Bedetti, Licia Lugli, Isotta Guidotti, Maria Federica Roversi, Elisa Della Casa Muttini, Marisa Pugliese, Natascia Bertoncelli, Eugenio Spaggiari, Alessandra Todeschini, Gina Ancora, Sara Grandi, Giancarlo Gargano, Claudio Gallo, Mario Motta, Piero Catenazzi, Luigi Tommaso Corvaglia, Vittoria Paoletti, Agostina Solinas, Elisa Ballardini, Serafina Perrone, Sabrina Moretti, Marcello Stella, Alberto Berardi, Fabrizio Ferrari   +23 more
wiley   +1 more source

Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model. [PDF]

Clinicoecon Outcomes Res
Smith T, Young A, O'Brien C, Duncan J, Rashid M, Magee T, Fitzgerald K, Vassar M.   +7 more
europepmc   +1 more source

Challenges and Considerations in Manipulating Oral Dosage Forms in Paediatric Healthcare Settings: A Narrative Review

Acta Paediatrica, EarlyView.
A substantial proportion of oral drug administrations in children require manipulation due to the lack of age‐appropriate formulations. Common methods such as splitting, crushing, and dispersing tablets in fluids can compromise dose accuracy because of e.g., drug solubility.
M. Paulsson, R. Hamre Svendsen, J. K. N. Andersen, S. Kälvemark Sporrong, Y. Andersson, I. Tho   +5 more
wiley   +1 more source